
-
Ill Mbappe out of second Real Madrid Club World Cup clash
-
Lehecka stuns Draper to reach Queen's final
-
Marc Marquez continues MotoGP dominance by winning Mugello sprint
-
Bangladesh draw first Test with Sri Lanka after rain hampers play
-
Pant scores India's third hundred in 1st Test before England hit back
-
Vondrousova surprises Sabalenka to reach Berlin final
-
Mexican boxing legend Alvarez promises Crawford bout will be one of his 'best'
-
French scientists find new blood type in Guadeloupe woman
-
Farrell adamant Lions 'won't suger-coat' Argentina loss
-
Malaysia's Dayaks mark rice harvest end with colourful parade
-
Shanto clinches second ton as Bangladesh set Sri Lanka 296-run target
-
Israel says killed three Iranian commanders in fresh wave of strikes
-
Crusaders out-muscle Chiefs to clinch 15th Super Rugby crown
-
VP Vance says US troops still 'necessary' in Los Angeles
-
Australian opener Konstas says he has 'come a long way'
-
'Survive, nothing more': Cuba's elderly live hand to mouth
-
Last member of K-pop megaband BTS to finish military service
-
Olympic balloon to rise again in Paris
-
Samaranch Senior -- controversial diplomat who saved the Olympics
-
As sports embrace gender tests, Coventry and IOC may follow
-
Flamengo floor Chelsea at Club World Cup, Bayern edge out Boca
-
Bayern overcome battling Boca to reach Club World Cup last 16
-
Jeeno extends lead at Women's PGA Championship
-
Israel says delayed Iran's presumed nuclear programme by two years
-
Japan-US-Philippines coast guards simulate crisis amid China threat
-
Flamengo floor Chelsea at Club World Cup, Bayern face Boca
-
Tech-fueled misinformation distorts Iran-Israel fighting
-
Panama declares state of emergency over deadly pension protests
-
Trump says Iran has 'maximum' two weeks, dismisses Europe peace efforts
-
Defending champions Toulouse hold off Bayonne to reach Top 14 final
-
Teams from 'south' have Club World Cup heat advantage: Dortmund's Kovac
-
'It's only match one' says Itoje after Lions mauled by Pumas
-
Fleetwood, Thomas and Scheffler share PGA Travelers lead
-
Mexican authorities rescue 3,400 trafficked baby turtles
-
Maresca accepts Chelsea were second best in Flamengo loss
-
Global stocks mixed, oil lower as market digests latest on Iran
-
Argentina's Kirchner urges backers not to gather as police deploy
-
Lions slump to warm-up defeat by Argentina
-
Habz, Stark light up Diamond League as Girma banishes Paris blues
-
Haliburton warns Pacers of 'poison' of outside noise before NBA Finals game 7
-
Benfica knock out Auckland in delayed Club World Cup romp
-
Benfica knock out Auckland in Club World Cup romp
-
Flamengo fightback floors Chelsea at Club World Cup
-
Jaiswal salutes 'special' hundred as Vaughan 'staggered' to see England bowl first
-
Wirtz wants to 'win everything' for Liverpool after record move
-
World Bank and IMF climate snub 'worrying', says COP29 presidency
-
Iran rejects nuclear talks with US before Israeli 'aggression' stops
-
Sahel juntas pile pressure on foreign mining firms
-
Europe powers urge Iran to keep up diplomacy despite Israeli strikes
-
Sabalenka saves four match points against Rybakina to reach Berlin semis

Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
Z.AlNajjar--SF-PST